Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

12220686

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Cell specific replication-competent viral vectors comprising a self processing peptide cleavage sequence are provided. The targeted replication-competent viral vectors include two or more co-transcribed genes under transcriptional control of the same heterologous transcriptional regulatory element (TRE), wherein at least a second gene is under translational control of a self processing cleavage sequence or 2A sequence. Exemplary vector constructs may further include an additional proteolytic cleavage site which provides a means to remove the self processing peptide sequence from the viral vector.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOSANTE PHARMACEUTICALS INC111 BARCLAY BLVD LINCOLNSHIRE IL 60609

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fang, Jianmin Palo Alto , US 148 2442
Harding, Thomas San Francisco , US 28 160
Ko, Derek Chicago , US 3 13
Li, Yuanhao Palo Alto , US 17 191
Ramesh, Nagarajan Sunnyvale , US 15 60
Yu, De-Chao Palo Alto , US 19 249

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation